Grifols SA (ADR) - Level III Live Stock Price Today, Share Analysis and Chart

Name: Grifols SA - ADR - Level III: Is Infosys Ltd. worth buying?
Item: Grifols SA - ADR - Level III
Rating: 1.78733325
Author: Trendlyne DVM scores

about

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once i...

8.89 -0.04 (-0.45%)

43.62% Gain from 52W Low

522.2K

XNAS Volume

XNAS 16 Jan, 2026 4:30 PM (EST)

Not Eligible

Expensive Valuation

28.3 / 100

Technically Neutral

43.2 / 100

1Yr Price target upside is 25%

2 analysts

Grifols SA (ADR) - Level III Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..